almotriptan has been researched along with Hypomenorrhea in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acuto, G; Allais, G; Allais, R; Benedetto, C; Bussone, G; D'Andrea, G; d'Onofrio, F; Grazzi, L; Manzoni, GC; Moschiano, F; Valguarnera, F | 1 |
Bartolini, M; Brighina, F; Ferrari, MD; Fierro, B; Giamberardino, MA; Lisotto, C; Martelletti, P; Moscato, D; Omboni, S; Panascia, B; Pini, LA; Sances, G; Santoro, P; Savi, L; Zanchin, G | 1 |
2 trial(s) available for almotriptan and Hypomenorrhea
Article | Year |
---|---|
Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Animals; Cross-Over Studies; Double-Blind Method; Female; Follow-Up Studies; Humans; Menstruation Disturbances; Middle Aged; Migraine Disorders; Placebos; Prospective Studies; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Young Adult | 2011 |
Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study.
Topics: Adult; Carbazoles; Cross-Over Studies; Disability Evaluation; Double-Blind Method; Female; Humans; Italy; Menstruation Disturbances; Middle Aged; Migraine Disorders; Proportional Hazards Models; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Treatment Outcome; Tryptamines | 2012 |